Search clinical trials for: Moxifloxacin 0.5%

Total 1846 results

RSP Systems A/S

Withdrawn

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device

Diabetes Mellitus

Denmark, Germany, Sweden, United Kingdom
Boehringer Ingelheim

Completed

Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)

Asthma
RSP Systems A/S

Completed

A Study of a Non-invasive Glucose Measuring Device in Out-patient Settings

Diabetes Mellitus

Germany
RSP Systems A/S

Completed

Study of a Non-invasive Glucose Measuring Device

Diabetes Mellitus

Germany
RSP Systems A/S

Completed

Study of a Novel Non-invasive Glucose Monitoring Device

Diabetes Mellitus

Denmark
Mayo Clinic

Completed

Mesenchymal Stem Cell Therapy for Lung Rejection

Bronchiolitis Obliterans | Lung Transplant Reject

United States
National University of Malaysia
Santen Pharmaceutical Co., Ltd.

Unknown

The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

Endophthalmitis

Malaysia
Spear Pharmaceuticals

Completed

Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo

Actinic Keratoses
Assiut University

Completed

Ultrasonographic Assessment of Lung Recruitment Maneuvers in Children Undergoing Lengthy Microsurgery Operations (RM)

Intraoperative Complications

Egypt
National University of Malaysia
Santen Pharmaceutical Co., Ltd.

Unknown

The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%

Endophthalmitis Postoperative

Malaysia
AstraZeneca
Fougera Pharmaceuticals Inc.

Withdrawn

A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)

Dermatitis
Oregon Health and Science University

Terminated

Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas

Hemangioma | Infant

United States
Mogilev Regional Clinical Hospital

Completed

Comparison of the Efficacy of 0.5% Bupivacaine, 0.5% Levobupivacaine, and 0.5% Hyperbaric Bupivacaine (BvsLBvsHB)

Anesthesia, Spinal

Belarus
Betaliq, Inc.
Trial Runners, LLC; Summit Analytical, LLC

Completed

Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Kocak Farma

Recruiting

Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo

COVID-19 Vaccine

Turkey
Shaperon

Completed

A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)

Atopic Dermatitis

Korea, Republic of
Bio-innova Co., Ltd

Not yet recruiting

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

Healthy Subjects
Dr. Christoph Ilies

Completed

Ultrasound Guided Intercostobrachial Nerve Block

Anaesthesia

Germany
National Institute of Hygiene and Epidemiology,...
Ministry of Health, Vietnam; Ministry of Science and Technology, Vietnam

Completed

Safety and Immunogenicity of JECEVAX in Young Children

Japanese Encephalitis

Vietnam
Reata, a wholly owned subsidiary of Biogen
AbbVie

Completed

RTA 408 Lotion in Healthy Volunteers

Healthy

United States
Bnai Zion Medical Center

Unknown

Comparison of Standard and Minidose Spinal Anesthesia for Cesarean Section Operation Using Marcaine Spinal 0.5% Heavy

Cesarean Section | Anesthesia, Spinal | Local Anaesthetics Causing Adverse Effects in Therapeutic Use

Israel
USDA Beltsville Human Nutrition Research Center
Penn State University

Completed

The Dose-Response Effects of Lean Beef in a Mediterranean-Style Dietary Pattern on Cardiovascular Disease Risk Factors

Healthy Volunteers

United States
Taro Pharmaceuticals USA

Completed

Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice

Pediculosis

India
Shenzhen Fifth People's Hospital

Recruiting

An Evaluation Trial About Anti-claudin18.2 the Specificity of Chimeric Antigen Receptor T Cells in the Advanced Gastric / Esophagogastric Junction Adenocarcinoma and Pancreatic Cancer Subjects

CAR T-Cell Therapy

China
AstraZeneca

Terminated

GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin

Type 2 Diabetes Mellitus

United States
Zhongshan Ophthalmic Center, Sun Yat-sen University

Completed

A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis

Vernal Keratoconjunctivitis
Dermax SA
bioRASI, LLC

Completed

Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts

External Anogenital Warts

Russian Federation, United States, Ukraine
Dalhousie University

Completed

Reversing the Effects of 0.5% Bupivacaine

Anesthesia, Local

Canada
Cara Therapeutics, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KARE)

Pruritus | Atopic Dermatitis

United States, Canada
Tongji Hospital

Unknown

Treatment of Calculous Pyonephrosis With 0.5% Iodophors for I-stage PCNL

Urolithiasis

China
Larissa University Hospital

Unknown

Effect of 0.5% vs 0.375% Ropivacaine on Autonomous Nervous System

Shoulder Surgery | Ropivacaine | Interscalene Nerve Block

Greece
Alcon Research

Completed

Assessment of Visual Performance in Patients With Low Levels of Astigmatism

Corneal Astigmatism | Cataract Extraction

United States
Jiangsu Province Centers for Disease Control and...
Wuhan Institute of Biological Products Co., Ltd

Withdrawn

A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and Adults

Healthy

China
Aerie Pharmaceuticals

Completed

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Ocular Hypertension | Open Angle Glaucoma

United States
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KIND-1)

Pruritus | Atopic Dermatitis

United States
AstraZeneca
Fougera Pharmaceuticals Inc.

Withdrawn

A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild to Moderate Plaque Psoriasis

Plaque Psoriasis
Vaxcyte, Inc.

Active, not recruiting

Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants

Pneumococcal Vaccines

United States
Alcon Research

Withdrawn

Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis

Bacterial Conjunctivitis
Galderma R&D

Completed

Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States
Sun Yat-sen University

Completed

Whitening Efficacy of Dentifrice Containing 10% High Cleaning Silica, 0.5% Sodium Phytate and 0.5% Sodium Pyrophosphate

Tooth Bleaching

China
Alcon Research

Completed

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma
National University of Malaysia
Santen Pharmaceutical Co., Ltd.

Unknown

Intracameral Levofloxacin (0.5%) vs Intracameral Cefuroxime

Endophthalmitis Postoperative

Malaysia
Actavis Inc.
Teva Pharmaceuticals USA

Completed

Clinical Endpoint Study of Ivermectin 0.5% Lotion

Head Lice

United States
H. Evren Eker
Baskent University

Completed

Intra-Articular 0.5 % Lidocaine Injection for Osteoarthritis

Chronic Pain
Mahidol University

Unknown

2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula

Infraclavicular Brachial Plexus Block

Thailand
Reata, a wholly owned subsidiary of Biogen
AbbVie

Completed

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Breast Cancer

United States
Baylor College of Medicine
The University of Texas Health Science Center, Houston; University of Pennsylvania and other collaborators

Completed

Studying Physiological and Anatomical Cerebral Effects of Carbon Dioxide and Tilt (SPACE-COT)

Healthy
GlaxoSmithKline

Completed

Bioequivalence Trial of Alprazolam 0.5 mg Tablets

Anxiety Disorders
Santen Pharmaceutical Co., Ltd.

Completed

DE-111 Against Timolol Ophthalmic Solution 0.5%

Ocular Hypertension | Open Angle Glaucoma

Japan
RSP Systems A/S
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft...

Completed

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use

Diabetes Mellitus

Germany

3

Subscribe